13G Filing: Healthcare Royalty Partners III, L.p. and Coherus Biosciences, Inc. (CHRS)

Page 9 of 14

Page 9 of 14 SEC Filing


CUSIP No. 19249H103
Item 1. (a) Name of Issuer
Coherus BioSciences, Inc.
(b) Address of Issuers Principal Executive Offices
333 Twin Dolphin Drive
Suite 600
Redwood City, CA 94065
Item 2. (a) Name of Person Filing
HealthCare Royalty Partners III, L.P.
HealthCare Royalty GP III, LLC
HealthCare Royalty Management, LLC
Todd C. Davis
Clarke B. Futch
Christopher A. White
Michael G. Carter
(b) Address of Principal Business Office, or if none, Residence:
The address of the principal business office of the reporting persons is:
300 Atlantic Street, Suite 600
Stamford, CT 06901
(c) Citizenship:
The place of organization of HealthCare Royalty Partners III, L.P., HealthCare Royalty GP III, LLC and HealthCare Royalty Management, LLC is Delaware. Messrs. Davis, Futch, White are each citizens of the United States, and Mr.
Carter is a citizen of the United Kingdom.
(d) Title of Class of Securities
Common stock, par value $0.0001 per share
(e) CUSIP Number
19249H103
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
HealthCare Royalty Partners III, L.P.: 3,355,402
HealthCare Royalty GP III, LLC: 3,355,402
HealthCare Royalty Management, LLC: 3,355,402
Todd C. Davis: 3,355,402
Clarke B. Futch: 3,355,402
Christopher A. White: 3,355,402
Michael G. Carter: 3,355,402

Page 9 of 16

Follow Coherus Biosciences Inc. (NASDAQ:CHRS)

Page 9 of 14